• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Neurology

Predicting persistent postconcussion symptoms with a clinical risk score

byAdarsh ManjunathandMichael Milligan
March 9, 2016
in Neurology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. In children presenting to an emergency department within 48 hours of an acute head injury, persistent postconcussion symptoms (PPCS) were present in 31% of patients.

2. A clinical risk score with 9 variables had modest discrimination to stratify PPCS risk at 28 days, with an area under the curve of 0.71.

Evidence Rating Level: 2 (Good)

Study Rundown: Concussion is a rising public health concern among children presenting to emergency departments. While many children stop experiencing symptoms within 2 weeks of a concussion, about a third of children have ongoing symptoms. Specifically, those symptoms persisting beyond 28 days are referred to as PPCS. The purpose of this study was to derive and validate a clinical risk score in children to stratify PPCS risk after a concussion. Among more than 2500 children who presented within 48 hours of an acute head injury and completed follow-up at 28 days, 801 (31%) had PPCS. During initial presentation, several variables were identified that were associated with an increased risk of developing PPCS, including female sex, age 13 years or older, fatigue, sensitivity to noise, headache, physician-diagnosed migraines, prior concussion with symptoms lasting longer than a week, answering questions slowly, and 4 or more errors on the Balance Error Scoring System tandem stance. Each patient could score a total of 12 points in the model. Low risk patients (<3 points) had a negative likelihood ratio of 0.36, and high risk patients (>9 points) had a positive likelihood ratio of 3, leading to an area under of the curve of 0.68.

In aggregate, the clinical risk score provided modest discrimination in stratifying PPCS risk at 28 days, thus allowing higher risk individuals to be identified and treated as early as possible. This study allows for generalizability given that participants had a wide age range and spectrum of injuries. However, there may have been selection bias in this study as children with concussions warranting emergency department care may be more likely to develop PPCS as compared to children with more mild concussions who did not present to a hospital.

Click to read the study in JAMA (Journal of the American Medical Association)

RELATED REPORTS

MLC901 may be effective in treatment of post-concussion symptoms in phase III study

Similar recovery course noted for both sports and non-sport-related concussion in children

Relevant Reading: Emergency department visits for concussion in young child athletes.

In-Depth [prospective cohort]: This prospective, multicenter cohort study recruited children ages 5 to 18 from 9 pediatric emergency departments within Canada between 2013 and 2015. In total, 2584 patients who presented within 48 hours of an acute head injury and who followed-up 28 days later were enrolled in both a derivation and validation cohort. There were 510 participants (30%) meeting criteria for PPCS in the derivation cohort, and 291 patients (33%) meeting criteria in the validation cohort. The variables included in the PPCS risk score model included female sex, age 13 years or older, fatigue, sensitivity to noise, headache, physician-diagnosed migraines, prior concussion with symptoms lasting longer than a week, answering questions slowly, and 4 or more errors on the Balance Error Scoring System tandem stance. The clinical risk score had modest discrimination to stratify PPCS risk at 28 days, with an area under the curve of 0.71 (95%CI 0.69-0.74) for the derivation cohort and 0.68 (95%CI 0.65-0.72) for the validation cohort.

 

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Concussion
Previous Post

HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital

Next Post

Appendicitis ruled out by clinical scoring in cases of equivocal ultrasound findings

RelatedReports

Prescription medicines collage: a mortar and pestle, a blister pack of white tablets, teal capsules and a glass beaker
Chronic Disease

MLC901 may be effective in treatment of post-concussion symptoms in phase III study

July 17, 2025
Chronic Disease

Similar recovery course noted for both sports and non-sport-related concussion in children

May 19, 2025
Chronic Disease

Mild traumatic brain injury associated with detectably neuroimaging changes and depressive symptoms

October 3, 2024
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Concussion Protocol, Monstrous Mosquitoes, Eye Transplants and Taking on 23andMe:

October 1, 2024
Next Post

Appendicitis ruled out by clinical scoring in cases of equivocal ultrasound findings

Patient and care transitions factors play role in preventable hospital readmissions

New vaccine shown to prevent a significant number of malaria cases in phase 3 trial

Artemisinin-based antimalarials may be safe and efficacious in pregnant women

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind November 16, 2026
  • ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice
  • Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.